MagAssist logo — company profile

MagAssist

Founded 2017 Series C Total: $600.00M Health Care

General Information

Company Name MagAssist
Founded Year 2017
Industries Health Care
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with MagAssist. To contact MagAssist, visit magassist.com.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MagAssist compare?

A PDF of MagAssist and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MagAssist soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MagAssist

MagAssist is a groundbreaking startup in the health care industry, founded in 2017 by Dr. Xu Bozhen—a distinguished expert in the National Youth Thousand People Program and a professor at Suzhou University. The company is dedicated to advancing a leading in vitro short-term ventricular assist device, a type of artificial heart. Its core team, comprising top-tier experts in artificial heart engineering technology, has extensive experience in international artificial heart R&D and commercialization. Notably, MagAssist has successfully developed a domestically produced artificial heart with independent intellectual property rights. The latest milestone for MagAssist came on 18 October 2021 with a significant CNY500.00M Series C investment led by prominent venture capital firms including Sequoia China, CH Innovations, and Cenova Capital. This substantial investment affirms the potential and value of MagAssist's innovative approach to in vitro short-term ventricular assist devices. With this funding, MagAssist is well positioned to further develop its technology, expand its market presence, and make a meaningful impact on the health care industry.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C CNY500.00M 3
Cenova, Sequoia Capital China +1
18 Oct 2021
Series B CNY100.00M 5
Northern Light Venture Capital, SND Ventures Group +3
14 Jan 2021
Series A Undisclosed 2
Med-Fine Capital, QS Capital
04 Jul 2019

MagAssist Alternatives & Competitors

MagAssist vs

臻Quan Biotechnology is a biotech company focused on the research, development, production, and sale...

Series A
Biotechnology, Health Care

FAQ About MagAssist

Suzhou Xinqing Medical Technology Co., Ltd., established in 2017 by Dr. Xu Bozhen—a distinguished expert in the National Youth Thousand People Program and a professor at Suzhou University—is committed to advancing a leading in vitro short-term ventricular assist device (a type of artificial heart)....
MagAssist was founded in 2017.
MagAssist operates in Health Care.
MagAssist has completed 3 funding rounds, raising a total of $600.00M. The latest funding stage is Series C.
Top alternatives and competitors to MagAssist include Zhenzhun Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MagAssist and Zhenzhun Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MagAssist, https://bouncewatch.com/company/magassist, updated 26 July 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes